You cannot register for this webinar

This webinar has ended. Thank you for your interest.

Topic
Oramed Pharmaceuticals (NASDAQ: ORMP) NASH Data and KOL Webinar
Date & Time

Selected Sessions:

Nov 17, 2022 04:00 PM

Description
Oramed to Host Webcast Highlighting Detailed Safety and Efficacy Data from Its Positive Phase 2 Clinical Trial of ORMD-0801 for NASH with Key Opinion Leader Discussion on Current Treatment Landscape